Insights on functionalized carbon nanotubes for cancer theranostics

L Tang, Q Xiao, Y Mei, S He, Z Zhang, R Wang… - Journal of …, 2021 - Springer
Despite the exciting breakthroughs in medical technology, cancer still accounts for one of
the principle triggers of death and conventional therapeutic modalities often fail to attain an …

Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade

RB Patel, R Hernandez, P Carlson… - Science translational …, 2021 - science.org
Molecular and cellular effects of radiotherapy on tumor microenvironment (TME) can help
prime and propagate antitumor immunity. We hypothesized that delivering radiation to all …

Clinical advances and perspectives in targeted radionuclide therapy

N Lepareur, B Ramée, M Mougin-Degraef… - Pharmaceutics, 2023 - mdpi.com
Targeted radionuclide therapy has become increasingly prominent as a nuclear medicine
subspecialty. For many decades, treatment with radionuclides has been mainly restricted to …

Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition

D Zboralski, F Osterkamp, E Christensen… - European Journal of …, 2023 - Springer
Purpose FAP is a membrane-bound protease under investigation as a pan-cancer target,
given its high levels in tumors but limited expression in normal tissues. FAP-2286 is a …

Recent pre-clinical advancements in nuclear medicine: pioneering the path to a limitless future

W Echavidre, D Fagret, M Faraggi, V Picco… - Cancers, 2023 - mdpi.com
Simple Summary This review summarizes recent advances in the nuclear medicine
theranostic approach. It covers the repurposing of historical radiotracers for new indications …

Cyclotron-produced 132La as a PET imaging surrogate for therapeutic 225Ac

E Aluicio-Sarduy, TE Barnhart, J Weichert… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The aim of this work was to explore 132La as a PET imaging surrogate for 225Ac using a
DOTA-based, tumor-targeting alkylphosphocholine (NM600). Methods: 132La was …

177Lu-Labeled Iron Oxide Nanoparticles Functionalized with Doxorubicin and Bevacizumab as Nanobrachytherapy Agents against Breast Cancer

EA Salvanou, A Kolokithas-Ntoukas, D Prokopiou… - Molecules, 2024 - mdpi.com
The use of conventional methods for the treatment of cancer, such as chemotherapy or
radiotherapy, and approaches such as brachytherapy in conjunction with the unique …

Development of radiotracers for breast cancer—the tumor microenvironment as an emerging target

A Heesch, J Maurer, E Stickeler, M Beheshti… - Cells, 2020 - mdpi.com
Molecular imaging plays an increasingly important role in the diagnosis and treatment of
different malignancies. Radiolabeled probes enable the visualization of the primary tumor as …

Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain

PA Clark, RN Sriramaneni, AM Bates… - Radiation …, 2021 - meridian.allenpress.com
Brain metastases develop in over 60% of advanced melanoma patients and negatively
impact quality of life and prognosis. In a murine melanoma model, we previously showed …

Metabolic imaging as a tool to characterize chemoresistance and guide therapy in Triple-Negative Breast Cancer (TNBC)

ED Sunassee, BV Jardim-Perassi, MC Madonna… - Molecular Cancer …, 2023 - AACR
After an initial response to chemotherapy, tumor relapse is frequent. This event is reflective
of both the spatiotemporal heterogeneities of the tumor microenvironment as well as the …